ProPhase Labs, Inc.
PRPH
$0.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.37% | -50.25% | -57.55% | -82.79% | -217.98% |
| Total Depreciation and Amortization | -23.86% | -14.52% | -9.40% | -4.07% | 2.67% |
| Total Amortization of Deferred Charges | 252.59% | 127.41% | 329.98% | 581.35% | 1,025.00% |
| Total Other Non-Cash Items | -128.97% | 374.38% | 306.97% | 47.06% | 155.50% |
| Change in Net Operating Assets | -101.24% | 317.68% | 796.55% | 374.73% | 321.50% |
| Cash from Operations | 52.42% | 28.03% | 27.32% | 9.85% | -47.53% |
| Capital Expenditure | -- | 96.38% | 97.80% | 98.40% | 56.53% |
| Sale of Property, Plant, and Equipment | -47.60% | -47.60% | 32.67% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -74.19% | -60.55% | -80.56% | -88.31% | 0.13% |
| Cash from Investing | -62.01% | -26.54% | -51.87% | -69.09% | 276.92% |
| Total Debt Issued | -23.20% | -4.70% | 85.65% | 209.19% | 29.76% |
| Total Debt Repaid | -0.28% | -131.66% | -561.26% | -2,912.43% | -- |
| Issuance of Common Stock | -53.15% | 41.18% | 12.09% | 806.00% | 532.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.58% | 6,093.75% | 9,630.00% | 23,775.00% | -- |
| Cash from Financing | -51.81% | -27.80% | -24.99% | 118.21% | 146.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.84% | 52.24% | 21.18% | 87.12% | 87.59% |